BICO Stock Overview
Operates as a bioconvergence company in North America, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BICO Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr44.82 |
| 52 Week High | kr72.30 |
| 52 Week Low | kr23.38 |
| Beta | 2.33 |
| 1 Month Change | -3.32% |
| 3 Month Change | 12.64% |
| 1 Year Change | -17.28% |
| 3 Year Change | -88.27% |
| 5 Year Change | -37.97% |
| Change since IPO | 228.95% |
Recent News & Updates
Recent updates
Here's Why BICO Group (STO:BICO) Can Afford Some Debt
Jul 01
The Market Doesn't Like What It Sees From BICO Group AB (publ)'s (STO:BICO) Earnings Yet As Shares Tumble 26%
Jun 08Why BICO Group AB (publ) (STO:BICO) Could Be Worth Watching
Dec 02Calculating The Fair Value Of BICO Group AB (publ) (STO:BICO)
May 20Is BICO Group AB (publ) (STO:BICO) Potentially Undervalued?
May 04Is BICO Group (STO:BICO) Using Too Much Debt?
Feb 09Health Check: How Prudently Does BICO Group (STO:BICO) Use Debt?
Oct 24Bullish: This Analyst Just Lifted Their Cellink AB (publ) (STO:CLNK B) Outlook For Next Year
Jul 22Does Cellink (STO:CLNK B) Have A Healthy Balance Sheet?
Jun 24Does Cellink (STO:CLNK B) Have A Healthy Balance Sheet?
Mar 07Shareholder Returns
| BICO | SE Life Sciences | SE Market | |
|---|---|---|---|
| 7D | -2.5% | 1.2% | -0.9% |
| 1Y | -17.3% | 3.9% | 14.2% |
Return vs Industry: BICO underperformed the Swedish Life Sciences industry which returned 3.9% over the past year.
Return vs Market: BICO underperformed the Swedish Market which returned 14.2% over the past year.
Price Volatility
| BICO volatility | |
|---|---|
| BICO Average Weekly Movement | 10.6% |
| Life Sciences Industry Average Movement | 5.6% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.9% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: BICO has not had significant price volatility in the past 3 months.
Volatility Over Time: BICO's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 837 | Maria Forss | www.bico.com |
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing.
BICO Group AB (publ) Fundamentals Summary
| BICO fundamental statistics | |
|---|---|
| Market cap | kr3.16b |
| Earnings (TTM) | -kr1.65b |
| Revenue (TTM) | kr2.43b |
1.3x
P/S Ratio-1.9x
P/E RatioIs BICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BICO income statement (TTM) | |
|---|---|
| Revenue | kr2.43b |
| Cost of Revenue | kr716.50m |
| Gross Profit | kr1.71b |
| Other Expenses | kr3.36b |
| Earnings | -kr1.65b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 20, 2024
| Earnings per share (EPS) | -23.37 |
| Gross Margin | 70.47% |
| Net Profit Margin | -67.97% |
| Debt/Equity Ratio | 47.1% |
How did BICO perform over the long term?
See historical performance and comparison